Page last updated: 2024-11-05

tolbutamide and Wolfram Syndrome

tolbutamide has been researched along with Wolfram Syndrome in 1 studies

Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.

Wolfram Syndrome: A hereditary condition characterized by multiple symptoms including those of DIABETES INSIPIDUS; DIABETES MELLITUS; OPTIC ATROPHY; and DEAFNESS. This syndrome is also known as DIDMOAD (first letter of each word) and is usually associated with VASOPRESSIN deficiency. It is caused by mutations in gene WFS1 encoding wolframin, a 100-kDa transmembrane protein.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ivask, M1
Hugill, A1
Kõks, S1

Other Studies

1 other study available for tolbutamide and Wolfram Syndrome

ArticleYear
RNA-sequencing of WFS1-deficient pancreatic islets.
    Physiological reports, 2016, Volume: 4, Issue:7

    Topics: Animals; Databases, Genetic; Gene Expression Profiling; Gene Expression Regulation; Gene Regulatory

2016